This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various biologically active molecules. Its structure, featuring a chroman core with fluorine substitutions, makes it valuable in the development of potential therapeutic agents, particularly in the area of central nervous system (CNS) disorders. Researchers explore its derivatives for their potential as selective receptor modulators or enzyme inhibitors, which could lead to treatments for conditions such as anxiety, depression, or neurodegenerative diseases. Additionally, its unique fluorinated structure enhances metabolic stability and bioavailability, making it a promising candidate for drug discovery and development.